Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02148874 · ClinicalTrials.gov registry record

Immune Responses to the Flu Shot During Pregnancy

A clinical trial of Pregnancy, sponsored by Lisa Christian.

Completed
Registry status
287
Enrollment target
1
Study location

NCT02148874: Completed study of Pregnancy, sponsored by Lisa Christian.

NCT02148874 is a study of Pregnancy that has completed, run by Lisa Christian. The registered enrollment target is 287 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02148874, a study of Pregnancy, has completed, sponsored by Lisa Christian.

COMPLETED
Registry status
287 participants
Enrollment target
1
Study location

Study Summary

This study will examine effects of everyday life stress and obesity on immune responses to influenza virus vaccine (the flu shot) during pregnancy. Following vaccination, antibody levels against influenza (the flu) increase. Higher antibody levels indicate better immune protection from influenza. In addition to providing protection from the flu for yourself, being vaccinated during pregnancy may protect your baby from the flu during the first six months of life during which time infants cannot be vaccinated. Our primary goals are to determine whether greater life stress and obesity reduce 1) antibody responses to the flu shot in women and 2) antibody levels in the newborn at the time of delivery.

Primary Outcome

Maternal influenza antibody titers from hemagglutination inhibition (HAI) assay

Conditions Studied

Interventions

  • BIOLOGICAL influenza virus vaccination

Study Locations (1)

Ohio

  • The Ohio State University Wexner Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 287 participants
Start Date 2013-10
Est. Completion 2019-08
Lisa Christian

1 total trials

What the finished NCT02148874 record still lists

NCT02148874 is an observational study that tracks outcomes without assigning an intervention. The registered 287 participants enrollment target is mid-sized for trials with a published cap, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (67% lower).

The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which influenza virus vaccination is the first listed.

NCT02148874 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT02148874 about?

NCT02148874 is a clinical study titled "Immune Responses to the Flu Shot During Pregnancy". This study will examine effects of everyday life stress and obesity on immune responses to influenza virus vaccine (the flu shot) during pregnancy. Following vaccination, antibody levels against influenza (the flu) increase. Higher antibody levels indicate better immune protection from influenza. In...

What is the current status of trial NCT02148874?

This trial is currently completed. The enrollment target is 287 participants. The study started on 2013-10. Estimated completion is 2019-08.

What conditions does trial NCT02148874 study?

This clinical trial studies the following conditions: Pregnancy.

What interventions are being tested in trial NCT02148874?

The interventions under investigation include: influenza virus vaccination (BIOLOGICAL).

Who is sponsoring clinical trial NCT02148874?

This trial is sponsored by Lisa Christian, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02148874 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02148874's enrollment target sits among peer trials

287 74th of 191 higher than 118 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03094429 · 287 participants · Phase 2

    An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

  • NCT06385080 · 287 participants · Phase 1

    A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

  • NCT06919224 · 287 participants · NA

    Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

  • NCT02098265 · 288 participants · NA

    A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02148874, the US trial registry maintained by the National Library of Medicine. NCT02148874 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.